A detailed history of Kure Advisory, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Kure Advisory, LLC holds 1,097 shares of JNJ stock, worth $218,939. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,097
Holding current value
$218,939
% of portfolio
0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 07, 2026

BUY
$185.98 - $199.58 $204,020 - $218,939
1,097 New
1,097 $227 Million
Q4 2023

Jan 12, 2024

BUY
$145.6 - $158.88 $20,529 - $22,402
141 Added 5.4%
2,752 $431 Million
Q3 2023

Oct 24, 2023

BUY
$155.75 - $174.48 $406,663 - $455,567
2,611 New
2,611 $407 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Kure Advisory, LLC Portfolio

Follow Kure Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kure Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kure Advisory, LLC with notifications on news.